Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study
R. Lord, S. Nair, A. Schache, J. Spicer, Navita Somaihah, V. Khoo, H. Pandha
The Journal of Urology
June 2007 (Vol. 177, Issue 6, Pages 2136-2140) Abstract |
Full Text |
Full-Text PDF (92 KB)
No abstract is available. To read the body of this article, please view the Full Text online.
Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado
